The group's principal activity is to provide high quality GLP in vitro drug metabolism and drug-drug interaction studies to pharmaceutical and chemical. The group’s products include Subcellular fractions, Hepatocytes, Recombinant CYPs, Antibodies, bDNA probe sets, and Transporter membranes. The group operates from the United States.
